Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Kalobios Pharmaceuticals Inc (KBIO)

Kalobios Pharmaceuticals Inc (KBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 32,806
  • Shares Outstanding, K 14,980
  • Annual Sales, $ 0 K
  • Annual Income, $ -27,010 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 2.99
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.67
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 09/22/17
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.5000 +46.00%
on 07/11/17
2.2000 -0.45%
on 08/04/17
+0.2400 (+12.31%)
since 07/03/17
3-Month
1.5000 +46.00%
on 07/11/17
2.9500 -25.76%
on 05/17/17
-0.1300 (-5.60%)
since 05/04/17
52-Week
1.5000 +46.00%
on 07/11/17
4.7500 -53.89%
on 12/09/16
-1.7700 (-44.70%)
since 08/04/16

Business Summary

KaloBios Pharmaceuticals, Inc. is a biopharmaceutical company. The Company develops monoclonal antibody therapeutics for the treatment of respiratory diseases and cancer. KaloBios Pharmaceuticals, Inc. is based in South San Francisco, California.

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 2.5833
1st Resistance Point 2.3867
Last Price 2.1900
1st Support Level 1.8067
2nd Support Level 1.4233
3rd Support Level N/A

See More

52-Week High 4.7500
Fibonacci 61.8% 3.5085
Fibonacci 50% 3.1250
Fibonacci 38.2% 2.7415
Last Price 2.1900
52-Week Low 1.5000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar